Milestone (MIST) Alert: Johnson Fistel Launches Investigation into Milestone Pharmaceuticals Inc.; Investors Suffering Losses Encouraged to Contact Firm
- Tuesday, March 24, 2020, 7:17
- PR Newswire
- Add a comment
SAN DIEGO, March 23, 2020 /PRNewswire/ — Shareholder Rights Law Firm Johnson Fistel, LLP, is investigating potential claims against Milestone Pharmaceuticals Inc. (NASDAQ: MIST) (“Milestone or the “Company”) for violations of federal securities laws. On or about May 9, 2019, Milestone…
About the Author
admin has written 21840 stories on this site.